NCDR launched with its flagship registry, the CAF PCI Registry, in 1998 and has since grown to become a suite of 10 registries, including hospital or inpatient registries, as well as ambulatory or outpatient-based registries. The CAF PCI Registry is a powerful tool which captures the data that measure adherence to ACC, AHA clinical practice guideline recommendations, procedure performance standards, and appropriate use criteria for coronary revascularization. In 2005, the ICD Registry was created for the quality improvement needs and assessment of ICD and CRTD device implants. The registry allowed hospitals across the nation to meet the Centers for Medicare and Medicaid Services requirement for reporting to a data registry based on their coverage determination. Reporting in the ICD Registry is still your most reliable way to track ongoing compliance with the updated CMS National Coverage Determination. Independent of this CMS requirement, the ICD Registry continues to be your most trusted source of evidence-based data collection and reporting for the ICD and CRTD procedures. The ICD Registry plays an important role in determining the association between evidence-based treatment strategies and clinical outcomes. The CARE Registry was launched in 2006 and has since been enhanced to become the PVI Registry. The CARE Registry was charged with data collection of carotid arteries in relation to stinting versus surgical interventions and was also used to provide a resource for extracting data required to be reported to CMS. Currently, the PVI Registry assesses the prevalence, demographics, management, and outcomes of patients undergoing lower extremity peripheral arterial catheter-based interventions and includes carotid artery stinting and carotid endarterectomies. The PVI Registry provides data collection and equips clinicians with decision-making data whether care is provided in a hospital cath lab, interventional radiology department, or an outpatient vascular center. In 2007, the ACTION Registry was created but has since been updated to its current branding, the Chest Pain MI Registry. The Chest Pain MI Registry is a risk-adjusted, outcomes-based quality improvement program that focuses exclusively on high-risk STEMI and in-STEMI patients. It helps hospitals apply ACC clinical guideline recommendations in their facilities and provides invaluable tools to measure care and achieve quality improvement goals. The first of our ambulatory registries was created in 2008 and was initially called the IC3 Registry. The branding has since been updated to the current registry now called the Pinnacle Registry. This registry is cardiology's largest outpatient quality improvement registry, capturing data on coronary artery disease, hypertension, heart failure, and atrial fibrillation. The IMPACT Registry was launched in 2010 and assesses the prevalence, demographics, management, and outcomes of pediatric and adult congenital heart disease patients undergoing diagnostic catheterizations and catheter-based interventions. Its data support the development of evidence-based guidelines for CHD treatment that will improve outcomes for CHD patients of all ages. In 2012, the STS-ACC-TVT Registry was created by a collaboration between the Society for Thoracic Surgeons and the ACC. This registry monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures, emerging treatments for valve disease patients. Employing state-of-the-art heart valve technology, transcatheter heart valve procedures provide new treatment options for patients who are not eligible for conventional heart valve replacement or repair surgery. In 2014, the second of ACC's NCDR ambulatory registries was launched. The Diabetes Collaborative Registry is the first global cross-specialty clinical registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum. In 2015, NCDR launched the LAAO Registry. The LAAO Registry captures data on left atrial appendage occlusion procedures to assess real-world procedural outcomes, short- and long-term safety, comparative effectiveness, and cost effectiveness. LAAO provides a treatment option to manage stroke risk for non-valvular atrial fibrillation patients who are unable to maintain adequate anticoagulation through medication therapy. The LAAO Registry is approved by the Centers for Medicare and Medicaid Services, otherwise known as CMS, to meet the registry requirements outlined in the National Coverage Decisions for Percutaneous Left Atrial Appendage Occlusures. And in 2016, the AFib Ablation Registry was launched. The AFib Ablation Registry assesses the prevalence, demographics, acute management, and outcomes of patients undergoing atrial fibrillation catheter ablation procedures. This data will support the development of evidence-based guidelines for AFib treatments that will improve outcomes for patients. The value of NCDR registry participation is recognized by thousands of hospitals and private practices within the United States, but also by many international facilities throughout the world as well. All 50 states in the United States of America and Puerto Rico participate in the NCDR suite of data registries, and the following countries are also leading the field in international participation. This list of countries will be expanding over time, and the current identified countries were participating as of March of 2019.

National Cardiovascular Data Registry

CAF PCI Registry

ICD Registry

CARE/PVI Registry

Chest Pain MI Registry